Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (771-780 of 819) with videos related to

Pageof 82
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancerM Dror Michaelson, Stephane Oudard, Yen-Chuan Ou, et al.
Journal for Immunotherapy of Cancer|June 18, 2015
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyHubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, et al.
European Urology|March 24, 2009
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogramFelix K Chun, Alexandre de la Taille, Hendrik van Poppel, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
Genome Medicine|April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapyAnna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
European Urology|September 18, 2025
Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical CystectomyMatthias Michael Heck, Jan Lehmann, Thomas Amiel, et al.
EMBO Molecular Medicine|December 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancerLatifa Zekri, Fabian Vogt, Lukas Osburg, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
Pageof 82

Showing results (771-780 of 819) with videos related to

Sort By:
Pageof 82
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancerM Dror Michaelson, Stephane Oudard, Yen-Chuan Ou, et al.
Journal for Immunotherapy of Cancer|June 18, 2015
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyHubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, et al.
European Urology|March 24, 2009
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogramFelix K Chun, Alexandre de la Taille, Hendrik van Poppel, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
Genome Medicine|April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapyAnna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
European Urology|September 18, 2025
Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical CystectomyMatthias Michael Heck, Jan Lehmann, Thomas Amiel, et al.
EMBO Molecular Medicine|December 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancerLatifa Zekri, Fabian Vogt, Lukas Osburg, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
Pageof 82